{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:41Z","timestamp":1790016941793,"version":"4.0.1"},"reference-count":109,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Inflammation plays a central role in the pathogenesis and progression of cardiovascular diseases, including atherosclerosis, myocardial infarction and heart failure. Despite advances in conventional diagnostic and therapeutic strategies, limitations in sensitivity, specificity and targeted drug delivery still remain. Nanomedicine has emerged as a promising yet underexplored approach to address these challenges by enabling precise molecular imaging and site-specific therapeutic interventions. This review summarizes current and emerging nanotechnology-based approaches for the diagnosis and treatment of cardiovascular inflammation, highlighting their potential in clinical practice and remaining challenges. In addition, recent advances, including the development of biomimetic nanoplatforms, are discussed, along with future perspectives and the potential integration of artificial intelligence to further enhance precision in cardiovascular medicine.<\/jats:p>","DOI":"10.3390\/jpm16060328","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:59:38Z","timestamp":1781773178000},"page":"328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanomedicine in Cardiovascular Inflammation: Novel Diagnostic and Therapeutic Strategies"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-5697","authenticated-orcid":false,"given":"Aikaterini-Eleftheria","family":"Karanikola","sequence":"first","affiliation":[{"name":"Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agapi","family":"Ploussi","sequence":"additional","affiliation":[{"name":"Department of Applied Medical Physics, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-9712","authenticated-orcid":false,"given":"Dimitrios","family":"Tsiachris","sequence":"additional","affiliation":[{"name":"Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-3353","authenticated-orcid":false,"given":"Efstathios P.","family":"Efstathopoulos","sequence":"additional","affiliation":[{"name":"Department of Applied Medical Physics, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/ATVBAHA.124.319980","article-title":"Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases","volume":"44","author":"Potere","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Liu, Y., Guan, S., Xu, H., Zhang, N., Huang, M., and Liu, Z. (2023). Inflammation Biomarkers Are Associated with the Incidence of Cardiovascular Disease: A Meta-Analysis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1175174"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Xu, L., Dong, N., and Li, F. (2022). NLRP3 Inflammasome: The Rising Star in Cardiovascular Diseases. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.927061"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology","volume":"87","author":"Mensah","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rehan, F., Zhang, M., Fang, J., and Greish, K. (2024). Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives. Molecules, 29.","DOI":"10.3390\/molecules29092073"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bayda, S., Adeel, M., Tuccinardi, T., Cordani, M., and Rizzolio, F. (2020). The History of Nanoscience and Nanotechnology: From Chemical\u2013Physical Applications to Nanomedicine. Molecules, 25.","DOI":"10.3390\/molecules25010112"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Omidian, H., Babanejad, N., and Cubeddu, L.X. (2023). Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071935"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jacc.2009.03.018","article-title":"The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation Using Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in Carotid Disease","volume":"53","author":"Tang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/CRD.0000000000000055","article-title":"Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging?","volume":"23","author":"Ploussi","year":"2015","journal-title":"Cardiol. Rev."},{"key":"ref_10","first-page":"6664471","article-title":"Targeting Nanostrategies for Imaging of Atherosclerosis","volume":"2021","author":"Grassia","year":"2021","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1021\/acsnano.3c03523","article-title":"A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque","volume":"17","author":"Gomez","year":"2023","journal-title":"ACS Nano"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10979","DOI":"10.1021\/acsomega.4c09170","article-title":"Noninvasive Detection of Macrophages in Atherosclerotic Lesions Using a Visipaque-Based Nanoparticle Contrast Agent for Computed Tomography","volume":"10","author":"Liang","year":"2025","journal-title":"ACS Omega"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.08.048","article-title":"Gold Nanoparticles-Based SPECT\/CT Imaging Probe Targeting for Vulnerable Atherosclerosis Plaques","volume":"108","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2967\/jnumed.115.166751","article-title":"PET\/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles","volume":"57","author":"Luehmann","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/acs.molpharmaceut.0c01183","article-title":"CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography\/Computed Tomography","volume":"18","author":"Detering","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ultrasmedbio.2013.12.013","article-title":"Nitric Oxide Pretreatment Enhances Atheroma Component Highlighting in Vivo with Intercellular Adhesion Molecule-1-Targeted Echogenic Liposomes","volume":"40","author":"Kee","year":"2014","journal-title":"Ultrasound Med. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1038\/s41598-024-63132-6","article-title":"Detection of Atherosclerotic Plaques with HDL-like Porphyrin Nanoparticles Using an Intravascular Dual-Modality Optical Coherence Tomography and Fluorescence System","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1703276","DOI":"10.1002\/adfm.201703276","article-title":"Quantum Dots Emitting in the Third Biological Window as Bimodal Contrast Agents for Cardiovascular Imaging","volume":"27","author":"Hu","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/CIRCIMAGING.112.974907","article-title":"Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients with Acute Myocardial Infarction: Early Clinical Experience","volume":"5","author":"Alam","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2011.06.004","article-title":"Magnetic Resonance Imaging (MRI) of Inflamed Myocardium Using Iron Oxide Nanoparticles in Patients with Acute Myocardial Infarction\u2014Preliminary Results","volume":"163","author":"Yilmaz","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14064","DOI":"10.1038\/ncomms14064","article-title":"Polyglucose Nanoparticles with Renal Elimination and Macrophage Avidity Facilitate PET Imaging in Ischaemic Heart Disease","volume":"8","author":"Keliher","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"114399","DOI":"10.1016\/j.jconrel.2025.114399","article-title":"Nanoparticle Immunoimaging Reveals Metabolic Dysfunction Fueling CCR2-Dependent Inflammation in Infarcted Hearts","volume":"389","author":"Elgrably","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12274-019-2280-4","article-title":"Infrared Fluorescence Imaging of Infarcted Hearts with Ag2S Nanodots","volume":"12","author":"Ortgies","year":"2019","journal-title":"Nano Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41565-020-0642-4","article-title":"Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging","volume":"15","author":"Senders","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.2147\/IJN.S176404","article-title":"MnO Nanoparticles with Potential Application in Magnetic Resonance Imaging and Drug Delivery for Myocardial Infarction","volume":"13","author":"Zheng","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.actbio.2024.01.017","article-title":"Early Detection of Cardiac Fibrosis in Diabetic Mice by Targeting Myocardiopathy and Matrix Metalloproteinase 2","volume":"176","author":"Liu","year":"2024","journal-title":"Acta Biomater."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.7150\/thno.34441","article-title":"Gold Nanoparticles That Target Degraded Elastin Improve Imaging and Rupture Prediction in an AngII Mediated Mouse Model of Abdominal Aortic Aneurysm","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115548","DOI":"10.1016\/j.colsurfb.2026.115548","article-title":"Nanomaterial Interventions in Abdominal Aortic Aneurysm (AAA): From Microenvironment Modulation to Vascular Reconstruction","volume":"262","author":"Jiang","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cvr\/cvae255","article-title":"CXCR4-Targeted Sensitive Magnetic Particle Imaging for Abdominal Aortic Aneurysm Early Detection and Prognosis Evaluation by Recognizing Total Inflammatory Cells","volume":"121","author":"Cao","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41420-024-02156-3","article-title":"Highly Sensitive Magnetic Particle Imaging of Abdominal Aortic Aneurysm NETosis with Anti-Ly6G Iron Oxide Nanoparticles","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2019.02.005","article-title":"Exosomes Derived from Mesenchymal Stem Cells Attenuate the Progression of Atherosclerosis in ApoE(-\/-) Mice via MiR-Let7 Mediated Infiltration and Polarization of M2 Macrophage","volume":"510","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"122890","DOI":"10.1016\/j.biomaterials.2024.122890","article-title":"Anti-Pyroptosis Biomimetic Nanoplatform Loading Puerarin for Myocardial Infarction Repair: From Drug Discovery to Drug Delivery","volume":"314","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the Management of Acute Coronary Syndromes: Developed by the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12951-022-01686-1","article-title":"Thrombus-Specific\/Responsive Biomimetic Nanomedicine for Spatiotemporal Thrombolysis and Alleviation of Myocardial Ischemia\/Reperfusion Injury","volume":"20","author":"Guo","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1186\/s12951-025-03810-3","article-title":"A Mitochondria-Targeted Nanomedicine for Myocardial Ischemia\/Reperfusion Injury with Synergistic Antioxidant and Anti-Inflammatory Properties","volume":"23","author":"Li","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/17435889.2024.2402678","article-title":"Cardiac-Targeted and ROS-Responsive Liposomes Containing Puerarin for Attenuating Myocardial Ischemia-Reperfusion Injury","volume":"19","author":"Wang","year":"2024","journal-title":"Nanomedicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1021\/acsnano.3c01760","article-title":"NLRP3 Inflammasome-Targeting Nanomicelles for Preventing Ischemia\u2013Reperfusion-Induced Inflammatory Injury","volume":"17","author":"Prakash","year":"2023","journal-title":"ACS Nano"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e11470","DOI":"10.1002\/adfm.202511470","article-title":"Adipose-Derived Active Nanoparticles-Loaded Biomimetic Cardiac Patch for Myocardial Infarction Repair","volume":"36","author":"Lin","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/acs.nanolett.4c04462","article-title":"Rational Design of Genetically Engineered Mitochondrial-Targeting Nanozymes for Alleviating Myocardial Ischemic-Reperfusion Injury","volume":"25","author":"Zhang","year":"2025","journal-title":"Nano Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.niox.2024.01.007","article-title":"In Vivo Testing of Novel Nitric Oxide-Releasing Nanoparticles for Alleviating Heart Failure Using the Zebrafish Embryo Model","volume":"144","author":"Hasan","year":"2024","journal-title":"Nitric Oxide"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.7150\/thno.61875","article-title":"Pulmonary Circulation-Mediated Heart Targeting for the Prevention of Heart Failure by Inhalation of Intrinsically Bioactive Nanoparticles","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110673","DOI":"10.1016\/j.abb.2025.110673","article-title":"MiR-133a Encapsulated in Hyaluronic Acid Nanoparticles Alleviates Sepsis-Induced Cardiomyopathy by Decreasing M1 Macrophage Polarization via the SOCS3\/JAK\/STAT3 Pathway","volume":"775","author":"Zheng","year":"2026","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103897","DOI":"10.1016\/j.redox.2025.103897","article-title":"GDF15 Nanotherapy Ameliorates NLRP3-Associated Redox Imbalance and Cardiac Injury in Sepsis","volume":"88","author":"Guo","year":"2025","journal-title":"Redox Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"66298","DOI":"10.1021\/acsami.5c15154","article-title":"Targeted Delivery of AGO-2 to Myocardial Mitochondria via Functionalized Nanoparticles Attenuates Oxidative Stress in Diabetic Cardiomyopathy","volume":"17","author":"Du","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.bbrc.2018.08.012","article-title":"Intravenous Mesenchymal Stem Cell-Derived Exosomes Ameliorate Myocardial Inflammation in the Dilated Cardiomyopathy","volume":"503","author":"Sun","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.actbio.2025.09.013","article-title":"Nanoparticles Coated with Immune Cell Hybrid Membranes for Targeted Delivery of Janus Kinase Inhibitors and Synergistic Treatment of Autoimmune Myocarditis","volume":"205","author":"Zhang","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.2147\/IJN.S487598","article-title":"T Lymphocyte-Macrophage Hybrid Membrane-Coated Biomimetic Nanoparticles Alleviate Myocarditis via Suppressing Pyroptosis by Targeting Gene Silencing","volume":"19","author":"Xiong","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"112492","DOI":"10.1016\/j.msec.2021.112492","article-title":"Bioinspired Macrophage-Targeted Anti-Inflammatory Nanomedicine: A Therapeutic Option for the Treatment of Myocarditis","volume":"131","author":"Toita","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ayodele, S., Kumar, P., van Eyk, A., van der Bijl, P., and Choonara, Y.E. (2025). Oligosaccharide Lactate Nanoparticles Enhance Tissue Targeting: A Case Study of the Controlled Delivery of Bedaquiline to Cardiac Tissue in TB Pericarditis. Molecules, 30.","DOI":"10.3390\/molecules30132845"},{"key":"ref_50","first-page":"9816234","article-title":"Localized Myocardial Anti-Inflammatory Effects of Temperature-Sensitive Budesonide Nanoparticles during Radiofrequency Catheter Ablation","volume":"2022","author":"Liu","year":"2026","journal-title":"Research"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.54379","article-title":"Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes\/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe(-\/-) Mice","volume":"29","author":"Katsuki","year":"2022","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102564","DOI":"10.1016\/j.nano.2022.102564","article-title":"Galactose-Modified Nanoparticles for Delivery of MicroRNA to Mitigate the Progress of Abdominal Aortic Aneurysms via Regulating Macrophage Polarization","volume":"44","author":"Chen","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13837","DOI":"10.2147\/IJN.S534411","article-title":"Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation","volume":"20","author":"Li","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20472","DOI":"10.1021\/acsnano.4c16585","article-title":"Inflammatory Macrophage-Targeted Atherosclerosis Treatment by MiRNA-Delivered, MRI-Visible, and Anti-Inflammatory Nanomedicine","volume":"19","author":"Li","year":"2025","journal-title":"ACS Nano"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2206129","DOI":"10.1002\/adma.202206129","article-title":"Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management","volume":"35","author":"Ma","year":"2023","journal-title":"Adv. Mater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.7150\/thno.59759","article-title":"Macrophage Targeted Theranostic Strategy for Accurate Detection and Rapid Stabilization of the Inflamed High-Risk Plaque","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2414740","DOI":"10.1002\/advs.202414740","article-title":"Injured Myocardium-Targeted Theranostic Nanoplatform for Multi-Dimensional Immune-Inflammation Regulation in Acute Myocardial Infarction","volume":"12","author":"Zheng","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Vargas, I., Grabau, R.P., Chen, J., Weinheimer, C., Kovacs, A., Dominguez-Viqueira, W., Mitchell, A., Wickline, S.A., and Pan, H. (2023). Simultaneous Inhibition of Thrombosis and Inflammation Is Beneficial in Treating Acute Myocardial Infarction. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087333"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e08419","DOI":"10.1002\/smll.202508419","article-title":"Cerium Oxide Doped Prussian Blue Nanoparticles for Targeted Modulation of the Myocardial Injury Microenvironment and Theranostics of Doxorubicin-Induced Cardiomyopathy","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Henein, M.Y., Vancheri, S., Longo, G., and Vancheri, F. (2022). The Role of Inflammation in Cardiovascular Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112906"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","article-title":"Macrophage-Targeted Nanomedicine for the Diagnosis and Treatment of Atherosclerosis","volume":"19","author":"Chen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lenz, T., Nicol, P., Castellanos, M.I., Engel, L.-C., Lahmann, A.L., Alexiou, C., and Joner, M. (2020). Small Dimension\u2014Big Impact! Nanoparticle-Enhanced Non-Invasive and Intravascular Molecular Imaging of Atherosclerosis In Vivo. Molecules, 25.","DOI":"10.3390\/molecules25051029"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Li, J., Centurion, F., Chen, R., and Gu, Z. (2023). Intravascular Imaging of Atherosclerosis by Using Engineered Nanoparticles. Biosensors, 13.","DOI":"10.3390\/bios13030319"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in Acute Myocardial Infarction: The Good, the Bad and the Ugly","volume":"45","author":"Matter","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, X., Tian, P.-C., Wang, K., Wang, M., and Wang, K. (2022). Pyroptosis: Role and Mechanisms in Cardiovascular Disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.897815"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Liu, C., Fan, Z., He, D., Chen, H., Zhang, S., Guo, S., Zheng, B., Cen, H., Zhao, Y., and Liu, H. (2022). Designer Functional Nanomedicine for Myocardial Repair by Regulating the Inflammatory Microenvironment. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040758"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2025.07.064","article-title":"Targeting Inflammation After Acute Myocardial Infarction","volume":"86","author":"Imbesi","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"126226","DOI":"10.1016\/j.ijpharm.2025.126226","article-title":"Nanomedicine-Based Approaches to Protect Cardiac Tissue Necrosis from Ischemic Events","volume":"690","author":"Nematpour","year":"2026","journal-title":"Int. J. Pharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10557-021-07239-2","article-title":"Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation","volume":"36","author":"Wang","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"126153","DOI":"10.1016\/j.ijpharm.2025.126153","article-title":"Nanodrug Targeting for Myocardial Ischemia-Reperfusion Injury: Mechanisms, Therapeutic Strategies, and Challenges in Clinical Translation","volume":"684","author":"Li","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: Developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) With the Special Contributio","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"133281","DOI":"10.1016\/j.ijcard.2025.133281","article-title":"Inflammation in Chronic Heart Failure: An Unsolved Puzzle","volume":"432","author":"Trimarchi","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A Novel Paradigm for Heart Failure with Preserved Ejection Fraction: Comorbidities Drive Myocardial Dysfunction and Remodeling through Coronary Microvascular Endothelial Inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10741-025-10519-w","article-title":"A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure","volume":"30","author":"Serban","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ejhf.463","article-title":"A Specifically Designed Nanoconstruct Associates, Internalizes, Traffics in Cardiovascular Cells, and Accumulates in Failing Myocardium: A New Strategy for Heart Failure Diagnostics and Therapeutics","volume":"18","author":"Youker","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jat.70131","article-title":"Doxorubicin-Induced Cardiotoxicity: Comprehensive Pathway Insights and Advanced Preclinical Therapeutics","volume":"46","author":"Sharma","year":"2026","journal-title":"J. Appl. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Pamporis, K., Karakasis, P., Pantelidaki, A., Goutis, P.A., Grigoriou, K., Theofilis, P., Katsaouni, A., Botis, M., Karanikola, A.-E., and Milaras, N. (2025). Sepsis-Induced Cardiomyopathy and Cardiac Arrhythmias: Pathophysiology and Implications for Novel Therapeutic Approaches. Biomedicines, 13.","DOI":"10.3390\/biomedicines13112643"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Li, N., Zhou, H., and Tang, Q. (2018). MiR-133: A Suppressor of Cardiac Remodeling?. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00903"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/dom.16242","article-title":"Mechanisms of Diabetic Cardiomyopathy: Focus on Inflammation","volume":"27","author":"Bellemare","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the Management of Myocarditis and Pericarditis","volume":"46","author":"Collini","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"134249","DOI":"10.1016\/j.ijcard.2026.134249","article-title":"Inflammatory Cardiomyopathy: Position Paper of the Italian Society of Cardiology Working Group on Cardiomyopathies and Pericardial Diseases in Collaboration with the Italian Society of Cardiology Working Group on Cardiac Magnetic Resonance","volume":"451","author":"Imazio","year":"2026","journal-title":"Int. J. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCRESAHA.124.324674","article-title":"Clinical Characteristics and Mechanisms of Acute Myocarditis","volume":"135","author":"Heymans","year":"2024","journal-title":"Circ. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40265-025-02169-x","article-title":"Current Drug Treatment for Acute and Recurrent Pericarditis","volume":"85","author":"Bonaventura","year":"2025","journal-title":"Drugs"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ihara, K., and Sasano, T. (2022). Role of Inflammation in the Pathogenesis of Atrial Fibrillation. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.862164"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome Signaling in Atrial Fibrillation","volume":"79","author":"Amir","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"114575","DOI":"10.4330\/wjc.v17.i12.114575","article-title":"Complex Interrelationship and Therapeutic Advances in Diabetic Patients with Atrial Fibrillation","volume":"17","author":"Karanikola","year":"2025","journal-title":"World J. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s12951-025-03822-z","article-title":"Targeted Nanodelivery Strategies for Atrial Fibrillation: Concomitant Targeting of Fibrosis Suppression and Electrical Conduction Restoration through Advanced Nanobiotechnology","volume":"23","author":"Liang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2580730","DOI":"10.1080\/10717544.2025.2580730","article-title":"Nanotechnology-Based Targeted Regulation of NLRP3 Inflammasome: Therapeutic Strategies and Clinical Application Prospects in Inflammatory Diseases","volume":"32","author":"Zhao","year":"2025","journal-title":"Drug Deliv."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jfma.2020.11.004","article-title":"LncRNA NRON Promotes M2 Macrophage Polarization and Alleviates Atrial Fibrosis through Suppressing Exosomal MiR-23a Derived from Atrial Myocytes","volume":"120","author":"Li","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wang, Z., Tong, Q., Li, T., and Qian, Y. (2022). Nano Drugs Delivery System: A Novel Promise for the Treatment of Atrial Fibrillation. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.906350"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yuan, Z., Lu, Y., Wei, J., Wu, J., Yang, J., and Cai, Z. (2020). Abdominal Aortic Aneurysm: Roles of Inflammatory Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.609161"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"123910","DOI":"10.1016\/j.biomaterials.2025.123910","article-title":"Nanomedicine for Venous Thrombosis: Insights from an Inflammatory Perspective","volume":"329","author":"Zeng","year":"2026","journal-title":"Biomaterials"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"102343","DOI":"10.1016\/j.mtbio.2025.102343","article-title":"Cell Membrane Biomimetic Nanoplatforms: A New Strategy for Immune Escape and Precision Targeted Therapy","volume":"35","author":"Feng","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12951-024-02529-x","article-title":"High-Density Lipoprotein Mimetic Nano-Therapeutics Targeting Monocytes and Macrophages for Improved Cardiovascular Care: A Comprehensive Review","volume":"22","author":"Zhen","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"568282","DOI":"10.2147\/IJN.S568282","article-title":"Nanozyme-Based Anti-Inflammatory Strategies in Cardiovascular Disease Management: Clinical Prospects and Challenges","volume":"21","author":"Zhou","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.2147\/IJN.S540010","article-title":"Recent Advances in Nanozymes for the Treatment of Atherosclerosis","volume":"20","author":"Zou","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Othman Basri, N.A., Che Roos, N.A., Aminuddin, A., Hamid, A.A., Hui, C.K., Mahadi, M.K., Kumar, J., and Ugusman, A. (2026). Mechanistic Insights into the Cardioprotective Effects of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Ischemic Injury: A Systematic Review. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18030346"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"116933","DOI":"10.1016\/j.envres.2023.116933","article-title":"Advances in Nanobased Platforms for Cardiovascular Diseases: Early Diagnosis, Imaging, Treatment, and Tissue Engineering","volume":"238","author":"Shariati","year":"2023","journal-title":"Environ. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2021.08.002","article-title":"Advance Cardiac Nanomedicine by Targeting the Pathophysiological Characteristics of Heart Failure","volume":"337","author":"Lin","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"123271","DOI":"10.1016\/j.biomaterials.2025.123271","article-title":"Nanomedicines for Cardiovascular Diseases: Lessons Learned and Pathways Forward","volume":"320","author":"Mao","year":"2025","journal-title":"Biomaterials"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/1574888X15666200309143924","article-title":"Exosome and Biomimetic Nanoparticle Therapies for Cardiac Regenerative Medicine","volume":"15","author":"Stine","year":"2020","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","article-title":"Regulating Nanomedicines: Challenges, Opportunities, and the Path Forward","volume":"20","author":"Mangla","year":"2025","journal-title":"Nanomedicine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/heartjnl-2017-311688","article-title":"Ferumoxytol-Enhanced Magnetic Resonance Imaging in Acute Myocarditis","volume":"104","author":"Stirrat","year":"2018","journal-title":"Heart"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e70027","DOI":"10.1002\/wnan.70027","article-title":"Machine Learning and Artificial Intelligence in Nanomedicine","volume":"17","author":"Chou","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/17435390.2023.2186279","article-title":"Predicting the Toxicity of Nanoparticles Using Artificial Intelligence Tools: A Systematic Review","volume":"17","author":"Masoorian","year":"2023","journal-title":"Nanotoxicology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","article-title":"Computational Pharmaceutics\u2014A New Paradigm of Drug Delivery","volume":"338","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1039\/D5CS01406A","article-title":"Artificial Intelligence-Powered Nanomedicine","volume":"55","author":"Luo","year":"2026","journal-title":"Chem. Soc. Rev."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/6\/328\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:29:19Z","timestamp":1781774959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/6\/328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":109,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jpm16060328"],"URL":"https:\/\/doi.org\/10.3390\/jpm16060328","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}